Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.74 is 49% above its 3-year average of 7.23, near the high end of its 3-year range (0.00–11.77).
As of the fiscal period ended Tuesday, June 30, 2026. 6.63% above its 12-month average of 10.07.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.74.
QUICK RATIO (ACID-TEST)
10.74
QUICK RATIO (ACID-TEST) AVG TTM
10.07
QUICK RATIO (ACID-TEST) AVG 3Y
10.04
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.63%
CURRENT VS 3Y AVG
+6.99%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.16
median of 722 covered companies
CURRENT VS SECTOR MEDIAN
+240.31%
vs the sector median at left
Market Cap
$5.98B
Quick Ratio (Acid-Test)
30.96
TTM Avg
15.27
3Y Avg
11.45
5Y Avg
10.17
Market Cap
$5.93B
Quick Ratio (Acid-Test)
3.82
TTM Avg
3.07
3Y Avg
3.52
5Y Avg
5.23
Market Cap
$5.80B
Quick Ratio (Acid-Test)
3.49
TTM Avg
3.21
3Y Avg
3.75
5Y Avg
4.96
Market Cap
$5.77B
Quick Ratio (Acid-Test)
22.20
TTM Avg
29.94
3Y Avg
20.76
5Y Avg
18.56
Market Cap
$6.51B
Quick Ratio (Acid-Test)
2.89
TTM Avg
3.87
3Y Avg
3.94
5Y Avg
3.31
Market Cap
$6.54B
Quick Ratio (Acid-Test)
1.44
TTM Avg
1.17
3Y Avg
1.11
5Y Avg
1.26
Market Cap
$5.56B
Quick Ratio (Acid-Test)
1.36
TTM Avg
1.16
3Y Avg
1.16
5Y Avg
1.16
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GRAIL Inc. (GRAL) | $5.98B | 10.74 | 10.07 | 10.04 | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.98B | 30.96 | 15.27 | 11.45 | 10.17 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.93B | 3.82 | 3.07 | 3.52 | 5.23 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.80B | 3.49 | 3.21 | 3.75 | 4.96 |
| CG Oncology Inc. (CGON)vs › | $5.77B | 22.20 | 29.94 | 20.76 | 18.56 |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 2.89 | 3.87 | 3.94 | 3.31 |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.54B | 1.44 | 1.17 | 1.11 | 1.26 |
| RadNet, Inc. (RDNT)vs › | $5.53B | 1.48 | 1.94 | 1.50 | 1.26 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.56B | 1.36 | 1.16 | 1.16 | 1.16 |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.58B | 0.87 | 1.56 | 2.48 | 3.39 |
Quick Ratio
10.74
Excludes inventory
Current Ratio
10.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 10.74 |
| 2026-03-31 | 11.51 |
| 2025-12-31 | 11.77 |
| 2025-09-30 | 7.37 |
| 2025-06-30 | 8.95 |
| 2025-03-31 | 9.46 |
| 2024-12-31 | 10.42 |
| 2024-09-30 | 9.43 |
| 2024-06-30 | 11.26 |
| 2024-03-31 | 9.45 |
| 2023-12-31 | 0.82 |
| 2023-09-30 | 0.00 |
| 2023-06-30 | 0.00 |
| 2023-04-02 | 0.00 |
